<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ADAPALENE</span><br/>(a-da'pa-leen)<br/><span class="topboxtradename">Differin<br/></span><b>Classifications:</b> <span class="classification">skin and mucous membrane agent</span>; <span class="classification">antiacne</span>; <span class="classification">retinoid</span><br/><b>Prototype: </b>Isotretinoin<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.1% gel</p>
<h1><a name="action">Actions</a></h1>
<p>Adapalene is a topical retinoid-like compound that modulates cellular differentiation, keratinization, and inflammatory processes
         related to the pathology of acne vulgaris. Topical adapalene may normalize the differentiation of epithelial follicular cells.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Adapalene decreases inflammatory process and acne formation.</p>
<h1><a name="uses">Uses</a></h1>
<p>Topical treatment of acne vulgaris.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to adapalene or any of the components of the gel, irritating topical products, and sunburn.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Pregnancy (category C), lactation. Safety and effectiveness in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Acne</span><br/><span class="rdage">Adult:</span> <span class="rdroute"></span> Apply once daily to affected areas in evening<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Apply a thin film to clean skin, avoiding eyes, lips, mucous membranes, cuts, abrasions, eczematous or sunburned skin.</li>
<li>Do not apply to skin recently treated with preparations containing sulfur, resorcinol, or salicylic acid.</li>
<li>Store at 20°25° C (68°77° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Skin:</span>
<span class="speceff-common">Erythema, scaling, dryness, pruritus, burning</span>, skin irritation, stinging, sunburn, acne flares. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Minimal absorption through intact skin. <span class="typehead">Elimination:</span> Excreted primarily in bile. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor therapeutic effectiveness, which is indicated by improvement after 812 wk of treatment; early therapy may be
            marked by apparent worsening of acne.
         </li>
<li>
            							Note: Cutaneous reactions (e.g., erythema, scaling, pruritus) are common and normally diminish after first month of therapy.
            						
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Apply only as directed; excessive application will not result in faster healing but will cause marked redness, peeling, and
            discomfort.
         </li>
<li>Minimize exposure to sunlight and sunlamps, and use sunscreen and protective clothing as needed.</li>
<li>Do not breast feed while using this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>